
Cipla receives USFDA approval for Generic Abraxane
Cipla Limited has announced a significant milestone with the final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Paclitaxel Protein-bound Particles for Injectable Suspension ( …